These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stem cell therapies for Parkinson's disease: are trials just around the corner? Drouin-Ouellet J; Barker RA Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072 [No Abstract] [Full Text] [Related]
9. Bilirubin: A Promising Therapy for Parkinson's Disease. Jayanti S; Moretti R; Tiribelli C; Gazzin S Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207581 [TBL] [Abstract][Full Text] [Related]
10. MiRNAs participate in the diagnosis, pathogenesis and therapy of Parkinson's disease. Lu X; Cui Z; Liu S; Yin F Histol Histopathol; 2018 May; 33(5):447-453. PubMed ID: 29135019 [TBL] [Abstract][Full Text] [Related]
11. Defining disease-modifying therapies for PD--a road map for moving forward. Olanow CW; Kieburtz K Mov Disord; 2010 Sep; 25(12):1774-9. PubMed ID: 20839307 [TBL] [Abstract][Full Text] [Related]
15. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies. Barkhuizen M; Anderson DG; Grobler AF Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617 [TBL] [Abstract][Full Text] [Related]
16. Positive clinical data in Parkinson's and ischemia buoy gene therapy. Sheridan C Nat Biotechnol; 2007 Aug; 25(8):823-4. PubMed ID: 17687344 [No Abstract] [Full Text] [Related]
17. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Goldberg MS; Lansbury PT Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy approaches to Parkinson's disease: preclinical to clinical trials, or what steps to take to get there from here? Redmond DE Exp Neurol; 1997 Mar; 144(1):160-7. PubMed ID: 9126166 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Parkinson's disease : what's on the horizon? Wu SS; Frucht SJ CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989 [TBL] [Abstract][Full Text] [Related]
20. Clinical approaches to the development of a neuroprotective therapy for PD. Olanow CW; Kieburtz K; Katz R Exp Neurol; 2017 Dec; 298(Pt B):246-251. PubMed ID: 28622912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]